Centre for Bioengineering and Biotechnology
University of Waterloo, East Campus 4, Room 2001
200 University Avenue West
Waterloo , Ontario, N2L 3G1 Canada
519-888-4567 Ext 32732
The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 130 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
At the Centre for Bioengineering and Biotechnology, we have over 130 researchers working in areas as diverse as new pharmaceutical delivery systems, lab testing on technologies as small as a computer chip, better and lower cost imaging systems, and software solutions for healthcare. Our researchers span all departments of the faculties of engineering and science, and includes researchers from other faculties as well. The common thread between researchers is a dedication to understanding how technology can work in conjunction with biology and people to make a better world.
The Centre for Bioengineering and Biotechnology is focused on partnerships. Success in this area requires strong partnerships between researchers, students, industry, healthcare and government. For this reason, the Centre welcomes members from these communities and encourages them to join the Centre and participate in our research. We host industry focus days, seminars, workshops, student events, and help build the right teams to tackle the toughest problems. Come join us, and work towards a better, healthier world through technology.
- Catherine Burns, Director, Centre for Bioengineering and Biotechnology
Shawn Wettig and the Wettig lab are building new types of surfactants with the aim of improving how drugs are delivered into human bodies. By exploring the different ways that molecular structures can be altered to improve effectiveness of gemini surfactants, the researchers are developing and refining methods that have many applications. Surfactants are relied on by industry for thousands of products, but the Wettig lab is particularly interested in surfactants as a mode of delivering gene therapy.